371 related articles for article (PubMed ID: 10649243)
1. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
Kiba T; Numata K; Kitamura T; Morita K; Saito S; Sekihara H
Hepatogastroenterology; 2001; 48(38):427-31. PubMed ID: 11379324
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
Cancer; 1996 May; 77(9):1792-6. PubMed ID: 8646676
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection.
Khan KN; Yatsuhashi H; Yamasaki K; Yamasaki M; Inoue O; Koga M; Yano M
J Hepatol; 2000 Feb; 32(2):269-78. PubMed ID: 10707867
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients.
Castellano L; Calandra M; Del Vecchio Blanco C; de Sio I
J Hepatol; 1997 Nov; 27(5):862-70. PubMed ID: 9382974
[TBL] [Abstract][Full Text] [Related]
6. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC).
Mueller PR
Jpn J Cancer Res; 1995 Nov; 86(11):inside front cover. PubMed ID: 8567388
[No Abstract] [Full Text] [Related]
11. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
12. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.
Dettmer A; Kirchhoff TD; Gebel M; Zender L; Malek NP; Panning B; Chavan A; Rosenthal H; Kubicka S; Krusche S; Merkesdal S; Galanski M; Manns MP; Bleck JS
World J Gastroenterol; 2006 Jun; 12(23):3707-15. PubMed ID: 16773687
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
[TBL] [Abstract][Full Text] [Related]
14. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma.
Chen RC; Liao LY; Wang CS; Chen WT; Wang CK; Li YH; Tu HY; Chen PH
AJR Am J Roentgenol; 2003 Dec; 181(6):1647-52. PubMed ID: 14627590
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
[TBL] [Abstract][Full Text] [Related]
16. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.
Sato S; Shiratori Y; Imamura M; Teratani T; Obi S; Koike Y; Imai Y; Yoshida H; Shiina S; Omata M
J Hepatol; 2001 Aug; 35(2):225-34. PubMed ID: 11580145
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
18. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate.
Lencioni R; Paolicchi A; Moretti M; Pinto F; Armillotta N; Di Giulio M; Cicorelli A; Donati F; Cioni D; Bartolozzi C
Eur Radiol; 1998; 8(3):439-44. PubMed ID: 9510580
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
Ohnishi K; Yoshioka H; Ito S; Fujiwara K
Hepatology; 1998 Jan; 27(1):67-72. PubMed ID: 9425919
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma.
Tanikawa K; Majima Y
Hepatogastroenterology; 1993 Aug; 40(4):324-7. PubMed ID: 8406300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
